Schrodinger (NASDAQ: SDGR) net income
Schrodinger reported a net loss of $103.3m for fiscal 2025; in fiscal 2024 it reported a net loss of $187.1m. Earnings per share were −$1.41.
Schrodinger's best year of the last 7 was fiscal 2023. It reported a loss in 6 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$103.3m | — | −40.4% | −$1.41 |
| 2024 | −$187.1m | −559.5% | −90.2% | −$2.57 |
| 2023 | $40.7m | — | 18.8% | $0.57 |
| 2022 | −$149.2m | — | −82.4% | −$2.10 |
| 2021 | −$100.4m | — | −72.8% | −$1.42 |
| 2020 | −$24.5m | — | −22.6% | −$0.41 |
| 2019 | −$24.6m | — | −28.7% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Schrodinger net income compared with its sector
By net income for its latest fiscal year, Schrodinger ranks 337th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Schrodinger, −40.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 335th | ALX Oncology | −$101.7m | — |
| 336th | Perspective Therapeutics | −$103.1m | — |
| 337th | Schrodinger | −$103.3m | −40.4% |
| 338th | Enliven Therapeutics | −$103.7m | — |
| 339th | Nkarta | −$104.1m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Schrodinger
- How much did Schrodinger earn in fiscal 2025?
- Schrodinger reported a net loss of $103.3m for fiscal 2025. In fiscal 2024 it reported a net loss of $187.1m.
- What are the earnings per share of Schrodinger?
- They were −$1.41 in fiscal 2025, compared with −$2.57 in fiscal 2024.
- What was the most profitable year for Schrodinger?
- Of its last 7 fiscal years, fiscal 2023, with $40.7m.
- Where does Schrodinger rank in its sector by net income?
- It ranks 337th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Schrodinger come from?
- From the annual report (Form 10-K) that Schrodinger files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Schrodinger files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Schrodinger: the Schrodinger page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.